title: [Pathogenesis and treatment of multiple sclerosis. Review and personal results].
authors.forename: J M
authors.initials: JM
authors.lastname: Gérard
authors.forename: J
authors.initials: J
authors.lastname: Hildebrand
authors.forename: N
authors.initials: N
authors.lastname: Mavroudakis
authors.forename: G
authors.initials: G
authors.lastname: Monseu
authors.forename: S
authors.initials: S
authors.lastname: Przedborski
authors.forename: P
authors.initials: P
authors.lastname: Seeldrayers
authors.forename: J
authors.initials: J
authors.lastname: Wautier
authors.forename: D
authors.initials: D
authors.lastname: Zegers de Beyl
mesh_terms: D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage* / Q000009:adverse effects; D000328:Adult; D000368:Aged; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone
vernacular_title: Pathogénie et traitement de la sclérose en plaques. Revue et résultats personnels.